Johnson & Johnson Vaccine Rollout Begins In U.S. As COVID-19 Cases Tick Up
Johnson & Johnson has started shipping its first vaccine doses across the U.S., adding a third vaccine to the country's arsenal as public health officials warn of an uptick in cases.
Johnson & Johnson has begun shipping the first nearly four million doses of its newly-authorized COVID-19 vaccine across the country, officials said Monday, and is expected to further scale up supply in the coming weeks and months.
"We think literally within about the next 24 to 48 hours Americans should start receiving shots in arms," Alex Gorsky, Johnson & Johnson's chief executive officer and chairman of the board, told NBC's TODAY.
Both the Food and Drug Administration and the Centers for Disease Control and Prevention on the vaccine over the weekend, making it the third to receive authorization in the U.S. It's also the first single-dose vaccine to receive the blessing of U.S.
